KKR Considers Selling Stake in India’s $3 Billion JB Pharma, Sources Say

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Loans Loans Headlines News

Loans Loans Latest News,Loans Loans Headlines

KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter.

Bitcoin Rally Puts Token on Best Monthly Gain Since October ‘21Vietnam Seeks More IPOs, Share Sales to Boost Its Stock MarketEuro-Area Economic Confidence Unexpectedly Weakens on ServicesAudi Plans Full Takeover of Sauber to Run Own F1 Team for 2026Alecta Cuts Value of Landlord Heimstaden Bostad Stake by 19%St.

6 Trillion for Europe’s Bond BonanzaSantander Online Bank to Offer AI-Based Price Targets for StocksGates Foundation Funds African Scientists Searching for TB and Malaria CureTop India Airlines Optimistic on Deliveries Despite Supply WoesHong Kong Vows Return to Fiscal Balance as Deficit SurgesClimate Investors Warn the Right Is Winning the War on ESGUS, Philippines Pay Highest Economic Price for Climate-Fueled WeatherWorldline Sets New Targets, Says Chairman Hunt to Wrap in MarchClimate...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in LOANS

Loans Loans Latest News, Loans Loans Headlines